))
108: FSHD Radio Hot off the Press: Mel Hayes of Fulcrum with a REACH Trial Update
Manage episode 378196293 series 3410030
Contenido proporcionado por FSHD Straight Talk. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente FSHD Straight Talk o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Earlier this month, Fulcrum Therapeutics confirmed the completion of patient enrollment in the Phase 3 REACH clinical trial for losmapimod, a potential groundbreaking therapy for FSHD. Mel Hayes, Chief Operating Officer of Fulcrum sat down with Tim to discuss what this exciting milestone means and fill us in on the latest from Project Mercury.
Catch a new Hot off the Press episode on the 4th Thursday of every month. Listen on your favorite podcast app or watch on YouTube or Facebook. Subscribe to make sure you never miss an episode!
Catch a new Hot off the Press episode on the 4th Thursday of every month. Listen on your favorite podcast app or watch on YouTube or Facebook. Subscribe to make sure you never miss an episode!
152 episodios
Compartir
